Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine vs ketorolac for acute migraine attacks
IRCT20210129050168N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of morphine and ketorolac in migraine (2 arms), sponsored by Urmia University of Medical Sciences. Started May 2022; status: completed.
02
Drugs
morphineketorolac
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20210129050168N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210129050168N1.